110 related articles for article (PubMed ID: 6230055)
21. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Nishi I; Yokoyama T; Nakao I; Harashima S; Ohashi Y; Kanko T; Saito T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
[TBL] [Abstract][Full Text] [Related]
22. [Clinical trial of 5'-deoxy-5-fluorouridine in malignant tumors under cooperative study (phase II study)].
Murakami M; Ota K; Yasue M; Hoshino A; Kamiya O; Kinoshita T; Yamada M; Hiraiwa K; Hachisuka K; Yamaguchi A
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1026-35. PubMed ID: 2944975
[No Abstract] [Full Text] [Related]
23. [Clinical evaluation of S-1, a new anticancer agent, in patients with advanced gastrointestinal cancer. S-1 Cooperative Gastrointestinal Study Group].
Maehara Y; Sugimachi K; Kurihara M; Taguchi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):476-85. PubMed ID: 10097744
[TBL] [Abstract][Full Text] [Related]
24. [Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP].
Irie K; Yasutake K; Imamura Y; Yoshimura Y; Nakamura T; Yoshida M; Fujisawa T; Nishimura S; Mizogami H; Sawada Y
Gan To Kagaku Ryoho; 1986 May; 13(5):1893-6. PubMed ID: 3085595
[TBL] [Abstract][Full Text] [Related]
25. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
[TBL] [Abstract][Full Text] [Related]
26. [Clinical trial of 5'-DFUR against various malignant tumors].
Okumura T
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
[TBL] [Abstract][Full Text] [Related]
28. [Phase II study of mitoxantrone].
Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
[TBL] [Abstract][Full Text] [Related]
29. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
Meguro S; Nagata T; Yokoyama K; Chinen T; Kobayashi T; Yamazaki H; Kuraishi Y; Ichiba ; Abe M; Isogai Y
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
[TBL] [Abstract][Full Text] [Related]
30. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
Kimura K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of 5'-deoxy-5-fluorouridine between older cancer patients versus younger cancer patients].
Sumimura J; Morimoto Y; Miyazaki M; Ishikawa S; Nagai I
Gan To Kagaku Ryoho; 1999 Mar; 26(4):561-4. PubMed ID: 10097759
[No Abstract] [Full Text] [Related]
32. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
33. [Joint clinical Phase II study of SF-SP].
Sato T; Sato H; Hanatani Y
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321
[TBL] [Abstract][Full Text] [Related]
34. [Clinical trial on the effect of tegafur (SF-SP)].
Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
[TBL] [Abstract][Full Text] [Related]
35. [Phase I study of raltitrexed (ZD-1694)].
Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2075-84. PubMed ID: 9838910
[TBL] [Abstract][Full Text] [Related]
36. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
[TBL] [Abstract][Full Text] [Related]
38. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
40. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
Nakano Y; Ohota J; Fujita M; Taguchi T
Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]